Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
A genome-scale CRISPR-Cas9 screening in myeloma cells identifies regulators of immunomodulatory drug sensitivity. [electronic resource] by
- Liu, Jiye
- Song, Tianyu
- Zhou, Wenrong
- Xing, Lijie
- Wang, Su
- Ho, Matthew
- Peng, Zhengang
- Tai, Yu-Tzu
- Hideshima, Teru
- Anderson, Kenneth C
- Cang, Yong
Producer: 20190530
In:
Leukemia vol. 33
Availability: No items available.
|
|
5.
|
A novel BCMA PBD-ADC with ATM/ATR/WEE1 inhibitors or bortezomib induce synergistic lethality in multiple myeloma. [electronic resource] by
- Xing, Lijie
- Lin, Liang
- Yu, Tengteng
- Li, Yuyin
- Cho, Shih-Feng
- Liu, Jiye
- Wen, Kenneth
- Hsieh, Phillip A
- Kinneer, Krista
- Munshi, Nikhil
- Anderson, Kenneth C
- Tai, Yu-Tzu
Producer: 20201103
In:
Leukemia vol. 34
Availability: No items available.
|
|
6.
|
APRIL signaling via TACI mediates immunosuppression by T regulatory cells in multiple myeloma: therapeutic implications. [electronic resource] by
- Tai, Yu-Tzu
- Lin, Liang
- Xing, Lijie
- Cho, Shih-Feng
- Yu, Tengteng
- Acharya, Chirag
- Wen, Kenneth
- Hsieh, Phillip A
- Dulos, John
- van Elsas, Andrea
- Munshi, Nikhil
- Richardson, Paul
- Anderson, Kenneth C
Producer: 20190520
In:
Leukemia vol. 33
Availability: No items available.
|